Intech Biopharm (ROCO:6461) YoY EBITDA Growth : -26.40% (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Intech Biopharm YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Intech Biopharm's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -26.40%.

Intech Biopharm's EBITDA per Share for the three months ended in Mar. 2025 was NT$-0.41.

Intech Biopharm YoY EBITDA Growth Historical Data

The historical data trend for Intech Biopharm's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intech Biopharm YoY EBITDA Growth Chart

Intech Biopharm Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

44.43

-31.37

-0.22

3.55

1.45

Intech Biopharm Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															24.41	-24.10	-	-3.71	-26.40

Intech Biopharm YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Intech Biopharm's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-1.767	-	-1.793)	/	\| -1.793 \|
=	1.45 %

Intech Biopharm's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(-0.407	-	-0.322)	/	\| -0.322 \|
=	-26.40 %

Intech Biopharm YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Intech Biopharm's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Intech Biopharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intech Biopharm Ltd (ROCO:6461) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 36, Ruiguang Road, 3rd Floor, Lane 358, Neihu District, Taipei, TWN, 114

Website

https://www.intechbiopharm.com

Intech Biopharm Ltd is a biotechnology company. The company develops inhalation products including single or combination generic products and some new combinations or new formulation projects are under development. It develops drugs for the treatment of lung diseases such as asthma. It has operations in Taiwan, China, Hong Kong, and Others.

Intech Biopharm Headlines

No Headlines